Journal of Antivirals & Antiretrovirals
Open Access

Arterez Inc, White Lake, Michigan, United States

Publications

• Research Article   
  A Combo Compound Therapy Effectively Reduces SARS-CoV-1 Viral Load in Mouse Lung
  Author(s): Josefino B. Tunac*
  
  Objective: SARS-CoV disease caused by SARS-CoV-1 is of multifactorial etiology consisting of upstream and downstream phases. The upstream phase is the physical breach of the cells protective shield by extraneous stressors including the virus and environmental elements (xeno), while the downstream is a sequela of damages (plexic) manifested in various symptoms, herein called xenoplexic diseases. Symptom targeting drugs are ineffective and palliative at best. SARS-CoV is a xenoplexic disease best treated with a combo therapeutic strategy This study evaluates EmbotricinTM (EMB), a multicomponent compound, to treat SARS-CoV. Materials and methods: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1), strain Urbani (200300592), obtained from the Centers for Disease Control and Prevention (CDC, Atlanta, GA) was use.. View More»
  DOI: 10.37421/1948-5964.21.13.221

  Abstract HTML PDF